2Thomson KS,Mejglo ZA,Pearce GN et al.3Dimensional susceptibility testing of -lactam antibiotics[].Antimicrobial Agents and Chemotherapy.1984
3Thomson KS and Sanders CC.Detection of extendedspectrum -lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests[].Antimicrobial Agents and Chemotherapy.1992
4Vercauteren E,Descheemaeker P,Ieven M,et al.Comparison of the screening methods for detection of extended-spectrum -lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp.in a Belgian teaching hospital[].Journal of Clinical Microbiology.1997
6Oteo J, Campos J, Baquero F, et al.Antibiotic resistance in 1 962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Re- sistance Surveillance System(2001 )[J]. J Antimicrob Che- mother, 2002,50(6) :945.
7Cormican MG, Marshall SA, Jons RN. Detection of extended spectrum β- lactamases(ESBL) producing strains by the Etest, ESBL screen[J]. Clini Microbial, 1996,34(8) : 1880- 1884.
8戴自英.实用抗菌药物学[M].上海:上海科学技术出版社,2000.189.
9Pai H.The characteristics of extended-spectrum beta-lactamases in Korean isolates of Enterobacteriaceae[J].Yonsei Med J,1998,39:514.
10Sader HS,Jones RN,Gales AC,et al.Antimicrobial susceptibility patterns for pathogens isolates from patients in Latin American medical centers with a diagnosis of pneumonia:analysis of results from the SENTRY Antimicrobial Surveillance program(1997)SENTRY Latin American Study Group[J].Diagn Microbiol Infect Dis,1998,32:289
